Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Paradromics Inc., a brain implant rival to Elon Musk’s Neuralink Corp., is partnering with Saudi Arabia’s Neom to develop brain-computer interface therapies in the Middle East and North Africa.

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

"The Miami Project and the University of Miami are renowned for their pioneering research in neural interfaces for the treatment of debilitating neurological conditions," Neuralink co-founder and COO ...

A national study led by the University of Bristol has revealed that both the public and divorcees themselves have limited knowledge about the leg ...

CoinDCX is launching Bitcoin Chai Cafes at popular tea stalls near financial hubs and tech parks in India to educate people about Bitcoin. These cafes will use engaging decor and trivia to make ...

Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, according to a Jan. 27 news release. The investigational medical device clinical trial is assessing the safety and ...

The University of Miami on Monday announced it will be the second U.S.-based site for Elon Musk's Neuralink’s PRIME Study. The PRIME study or Precise Robotically Implanted Brain-Computer ...

The university will become the second U.S.-based site for Neuralink's Precise Robotically Implanted Brain-Computer Interface (PRIME) study.

There is a clear stress in the stroke of the sans serif letters, which is now often used as visual shorthand for the period,” says Marie. “It was very experimental work produced with extreme ...